logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12605455 B1

PDFFull Text
Date of Patent:
Apr. 21, 2026

Filed:

Mar. 19, 2021

Car peptide for improved coronavirus survival

Applicant:

Vascular Biosciences, San Diego, CA (US);

Inventor:

David Mann, San Diego, CA (US);

Assignee:

Vascular Biosciences, San Diego, CA (US);

Attorneys:

Lewis Kohn & Walker LLP

David M. Kohn

Kari Moyer-Henry

Primary Examiner:

Celeste A Roney

Int. Cl.
CPC ...
A61K 47/55 (2017.01); A61K 9/00 (2006.01); A61K 9/127 (2006.01); A61K 31/197 (2006.01); A61K 31/573 (2006.01); A61K 31/706 (2006.01); A61K 38/08 (2019.01); A61K 38/21 (2006.01); A61K 38/36 (2006.01); A61K 39/395 (2006.01); A61K 47/64 (2017.01); A61K 49/10 (2006.01); A61K 49/14 (2006.01); A61K 49/18 (2006.01); A61K 51/08 (2006.01); A61P 3/10 (2006.01); A61P 9/00 (2006.01); A61P 29/00 (2006.01); A61P 31/14 (2006.01); A61P 37/06 (2006.01);
U.S. Cl.
CPC ...
A61K 47/646 (2017.08); A61K 9/007 (2013.01); A61K 9/127 (2013.01); A61K 31/197 (2013.01); A61K 31/573 (2013.01); A61K 31/706 (2013.01); A61K 38/08 (2013.01); A61K 38/21 (2013.01); A61K 38/36 (2013.01); A61K 39/3955 (2013.01); A61K 47/55 (2017.08); A61K 49/106 (2013.01); A61K 49/14 (2013.01); A61K 49/1866 (2013.01); A61K 51/088 (2013.01); A61P 3/10 (2018.01); A61P 9/00 (2018.01); A61P 29/00 (2018.01); A61P 31/14 (2018.01); A61P 37/06 (2018.01);
Abstract

A conjugate for treating an individual suffering from a disease, wherein the conjugate is comprised of: a targeting peptide comprising a sequence substantially identical to CAR, or a variant thereof; and at least one therapeutic molecule and methods for making and administering same. Also disclosed is a combination product for use in the treatment of a disease, wherein the combination product comprises: (a) a targeting peptide comprising a sequence substantially identical to CAR, or a variant thereof; (b) a liposome, wherein the targeting peptide is encapsulated within the liposome; and (c) an effective amount of an anti-inflammatory agent and methods for making and administering same.

Find Patent Forward Citations

Mann, David. (2026). Car peptide for improved coronavirus survival (U.S. Patent No. 12605455). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12605455

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…